Changes in some hemostatic parameters in patients with infections treated with ceftazidime and latamoxef.
In comparative studies made in patients with pneumonia we have treated 14 cases with Latamoxef and 16 cases with Ceftazidime. We have concentrated our attention on the side effects of these drugs on hemostasis. In 8 patients treated with Latamoxef we have found a prolongation bleeding time, moderate hypoprothrombinemia, thrombocytopenia and nearly no normalization of APTT and plasma euglobulin fibrinolysis. In one patient treated with Ceftazidime only slight effect of this drug on hemostasis was observed. Crucial reason for coagulopathy is probably due to impaired synthesis of vitamin K by diminished gut flora conditioned by antibiotics treatment. In the case of Ceftazidime mentioned there seem to be minimal side effects.
D001424:Bacterial Infections / Q000097:blood / Q000188:drug therapy*; D001780:Blood Coagulation Tests; D002442:Ceftazidime / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D005260:Female; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009070:Moxalactam / Q000009:adverse effects*; D010976:Platelet Count; D011897:Random Allocation; D013997:Time Factors
D002442:Ceftazidime; D009070:Moxalactam